Table 2.

Patients enrolled and corresponding mutational analysis on tissue biopsy and liquid biopsy at the T0 time-point by microarray and ddPCR approaches.

Sample ID	Tissue Biopsy	Liquid Biopsy
		Microarray	ddPCR Mutated Allele %
1	KRAS G12D	KRAS G12D + G12R	KRAS G12D = 0.033 KRAS G12R = 0.95%
2	BRAF V600E	BRAF V600E	BRAF V600E = 15%
3	wt	wt	-
4	wt	wt	-
5	wt	wt	-
6	wt	wt	-
7	wt	KRAS G12C	KRAS G12C = 32.3%
8	wt	wt	-
9	wt	wt	-
10	wt	wt	-
11	wt	wt	-
12	wt	wt	-
13	KRAS A146T	KRAS A146T	KRAS A146T = 20%
14	KRAS G13D	KRAS G13D	KRAS G13D = 1.3%
15	wt	wt	-
16	KRAS A146T	KRAS A146T	KRAS A146T = 77.5%
17	wt	wt	-
18	KRAS G12D	KRAS G12D	KRAS G12D = 65.3%
19	KRAS G12S	KRAS G12S	KRAS G12S = 17.7%
20	KRAS G12D	KRAS G12D	KRAS G12D = 3.7%